par Francis, P;Crown, John;Di Leo, Angelo ;Buyse, Marc;Balil, A;Andersson, M;Nordenskjöld, B;Lang, Istvan;Jakesz, Raimund;Vorobiof, Daniel;Gutierrez, J;van Hazel, Guy;Dolci, Stella;Jamin, Sophie;Bendahmane, Belguendouz;Gelber, R D;Goldhirsch, Aron;Castiglione-Gertsch, Monica;Piccart-Gebhart, Martine ;BIG 02-98 Collaborative Group,
Référence Journal of the National Cancer Institute, 100, 2, page (121-133)
Publication Publié, 2008-01
Référence Journal of the National Cancer Institute, 100, 2, page (121-133)
Publication Publié, 2008-01
Article révisé par les pairs
Titre: |
|
Auteur: | Francis, P; Crown, John; Di Leo, Angelo; Buyse, Marc; Balil, A; Andersson, M; Nordenskjöld, B; Lang, Istvan; Jakesz, Raimund; Vorobiof, Daniel; Gutierrez, J; van Hazel, Guy; Dolci, Stella; Jamin, Sophie; Bendahmane, Belguendouz; Gelber, R D; Goldhirsch, Aron; Castiglione-Gertsch, Monica; Piccart-Gebhart, Martine; BIG 02-98 Collaborative Group, |
Informations sur la publication: | Journal of the National Cancer Institute, 100, 2, page (121-133) |
Statut de publication: | Publié, 2008-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adenocarcinoma -- chemistry |
Adenocarcinoma -- drug therapy | |
Adenocarcinoma -- pathology | |
Adenocarcinoma -- surgery | |
Adult | |
Aged | |
Antibiotics, Antineoplastic -- administration & dosage | |
Antineoplastic Agents, Phytogenic -- administration & dosage | |
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- chemistry | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- pathology | |
Breast Neoplasms -- surgery | |
Chemotherapy, Adjuvant | |
Cyclophosphamide -- administration & dosage | |
Disease-Free Survival | |
Doxorubicin -- administration & dosage | |
Drug Administration Schedule | |
Estrogen Receptor Modulators -- administration & dosage | |
Female | |
Fluorouracil -- administration & dosage | |
Follow-Up Studies | |
Humans | |
Immunohistochemistry | |
Kaplan-Meiers Estimate | |
Lymphatic Metastasis | |
Mastectomy -- methods | |
Methotrexate -- administration & dosage | |
Middle Aged | |
Odds Ratio | |
Prospective Studies | |
Receptors, Estrogen -- analysis | |
Receptors, Progesterone -- analysis | |
Tamoxifen -- administration & dosage | |
Taxoids -- administration & dosage | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase III |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, N.I.H., Extramural | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0027-8874 |
info:doi/10.1093/jnci/djm287 | |
info:pii/djm287 | |
info:scp/38449108413 | |
info:pmid/18182617 |